Medical Policy, Reimbursement Policy, Pharmacy Policy, & Provider Information
Providence Health Plan, Providence Health Assurance, and Providence Health Plan Partners
Select a topic below to access policies or more information:
-
Prior-authorization, Non-covered, and DME and Supplies Lists and Fax Forms
The following lists are intended to provide guidance regarding coverage of healthcare services and are not all inclusive. Additional exclusions may apply based on benefit and contract terms.
- How to use the prior-authorization list
- How to use the non-covered list
Please see the “Pharmacy Policies” section below for information regarding drugs that require authorization.
Vendor Sites for Prior Authorization Requests and Delegated Criteria
- Carelon Medical Benefits Management (Advanced Imaging)
- eviCore (Outpatient Rehab)
- American Specialty Health
- Providence Health Network
Beginning July 1, 2024, Carelon Medical Benefits Management may request additional clinical information for radiology pre-authorization requests. If requested, providers will need to submit documentation from the patient’s medical record to demonstrate that services are clinically appropriate.
For general questions or questions regarding criteria, please call 503-574-7500. InterQual, Level of Care Utilization (LOCUS), Child and Adolescent Level of Care Utilization System (CALOCUS), Child and Adolescent Service Intensity Instrument (CASII), American Society of Addiction Medicine (ASAM) criteria, can be disclosed to members and practitioners, upon request.
General Prior-authorization Requirements
- General PA Requirements Medicare HMO
- General PA Requirements PEBB Statewide and PEBB Choice
- General PA Requirements PPO
- General PA Requirements Standard
- General PA Requirements PHS Swedish, Kadlec, PacMed
- General PA Requirements OHP
Effective March 1, 2023, American Imaging Management/AIM Specialty Health and Beacon Health Options changed their names to Carelon. AIM transitioned to Carelon Medical Benefits Management, and Beacon Health Options transitioned to Carelon Behavioral Health. If you have questions about this change, please call 800-878-4445 or click here to learn more.
Prior-authorization Medical Fax Form
***Effective January 1, 2024, Yamhill Community Care Organization (YCCO) will be internally assuming all aspects of care management, utilization management, and grievance system activities. These services are currently contracted to PH Tech and Providence Plan Partners.
For any questions, please contact YCCO Customer service at 503-488-2800 or toll free at 855-722-8205.***
Prior-authorization Pharmacy Fax Form
Prior-authorization Behavioral Health Fax Forms
For new members, authorizations will be held until member eligibility can be verified.
- Prior authorization Facility based BH (Inpatient, Residential, Partial Hospital, and IOP PA) Form
- Prior Authorization BH Outpatient Fax Form
- Prior Authorization BH TMS Fax Form
- Prior Authorization BH ABA Fax Form
Ambulatory Surgery Center Access - Physician Attestation
Clinical Edit Inquiry Form
Clinical Edit Inquiry Form instructions
**Before sending in a Clinical Edit Inquiry form, review all applicable Payment Policies and Medical Director Edits.
This form can be completed by participating providers.
- Completely fill out the ‘Sender information’ box at the top of the form.
- Include the following as instructed on the form:
- Chart notes for date of service that support all procedures.
- Letter of explanation for the inquiry
- Check the box to identify which edit is being appealed. If the edit you are appealing is not listed, enter the edit code in the blank box.
- Pay close attention to which fax number is listed above the edit code that applies to ensure that the form is sent to the correct area.
Non- participating providers that are disputing a clinical edit would need to send information to the claim support team fax # 503-574-8146
eviCore High Tech Imaging Prior Authorization Code List
- eviCore High Tech Imaging Prior Authorization Code List - November 2024
- eviCore High Tech Imaging Prior Authorization Code List - October 2024
- eviCore High Tech Imaging Prior Authorization Code List - August 2024
- eviCore High Tech Imaging Prior Authorization Code List - July 2024
- eviCore High Tech Imaging Prior Authorization Code List - August 2023
- eviCore High Tech Imaging Prior Authorization Code List - April 2023
- eviCore High Tech Imaging Prior Authorization Code List - March 2023
- eviCore High Tech Imaging Prior Authorization Code List - January 2023
- eviCore High Tech Imaging Prior Authorization Code List - December 2022
-
Coding Policies and Alerts
Billing, Payment, and Coding Policy Alerts
- Coding Policy Alert November/December 2024
- Coding Policy Alert September/October 2024
- Coding Policy Alert July/August 2024
- Coding Policy Alert May/June 2024
- Coding Policy Alert March/April 2024
- Coding Policy Alert - Special Edition - February 2024
- Coding Policy Alert January/February 2024
- Coding Policy Alert November/December 2023
- Coding Policy Alert September/October 2023
- Coding Policy Alert July/August 2023
- Coding Policy Alert May/June 2023
- Coding Policy Alert March/April 2023
- Coding Policy Alert January/February 2023
- Coding Policy Alert - Special Edition - December 2022
- Coding Policy Alert November/December 2022
- Coding Policy Alert September/October 2022
- Coding Policy Alert July/August 2022
- Coding Policy Alert May/June 2022
- Coding Policy Alert March/April 2022
- Coding Policy Alert January/February 2022
- Coding Policy Alert September/October 2021
- Coding Policy Alert July/August 2021
- Coding Policy Alert May/June 2021
- Coding Policy Alert March/April 2021
- Coding Policy Alert January/February 2021
- Coding Policy Alert November/December 2020
- Coding Policy Alert October 2, 2020
- Coding Policy Alert September/October 2020
- Coding Policy Alert July/August 2020
- Coding Policy Alert June 26, 2020
- Coding Policy Alert April 2, 2020
- Coding Policy Alert March 26, 2020
- Coding Policy Alert March/April 2020
- Payment and Coding Policy Alerts – COVID-19 UPDATE
- Telehealth Services DURING COVID-19 CRISIS
Billing, Payment, and Coding Policies
- 01.0 Coding Policy Development
- 03.0 Assistant for Surgical Procedures
- 04.0 Procedure Specific Policies
- 05.0 Incidental and Mutually Exclusive Surgical Procedures
- 06.0 Multiple Surgery
- 07.0 Global Payment for Obstetrical Care DURING COVID-19 CRISIS
- 08.0 Duplicate Diagnostic Test Interpretations
- 09.0 Anesthesia
- 10.0 Modifier -22
- 11.0 Place of Service for Diagnostic Services
- 12.0 Global Surgical Package
- 13.0 Bundled or Adjunct Services
- 14.0 Bilateral Procedures
- 16.0 Co-Surgeons
- 18.0 Venipuncture
- 19.0 Service Code Policy
- 20.0 Split Global Surgical Package
- 22.0 HCPCS S-Codes
- 27.0 Billing Guidelines for New or Unlisted Codes
- 29.0 Date of Service for Professional Claims
- 30.0 Lab Panel Billing
- 31.0 Modifier -25
- 32.0 Modifier -57
- 33.0 Modifier 59 and Other Modifiers for Distinct Procedural Services
- 34.0 Administration of Immunizations and Injections
- 35.0 Laboratory Services, Professional Charges
- 39.0 Modifiers -73 and -74
- 41.0 Multiple Endoscopy
- 42.0 Modifiers GA, GY, and GZ
- 44.0 Facility Take Home Items
- 50.0 Modifier -63
- 51.0 Modifier 47
- 52.0 Medical Visits
- 53.0 Online Digital Evaluation and Management Services FOR COVID-19 PHE
- 57.0 Modifiers -52 and -53
- 58.0 Documentation Guidelines for Medical Services
- 60.0 Documentation Guidelines Amended Notes
- 63.0 Web-Based Dermatology Consultation for Review of Images
- 65.0 Guidelines for Billing Consultations
- 67.0 Telemedicine Services REQUIRING ORIGINATING SITE
- 67.0.A MEDICARE Telehealth Services DURING COVID-19 PHE
- 67.0.B COMMERCIAL OREGON PROVIDERS Telehealth Services DURING COVID-19 PHE
- 67.0.C OHP Telehealth Services DURING COVID-19 PHE
- 67.0.D COMMERCIAL WASHINGTON PROVIDERS Telehealth Services DURING COVID-19 PHE
- 67.0.E NONMEDICARE Telemedicine Services During COVID-19 PHE.
- 68.0 Limited Comparative Radiographic Exams
- 70.0 Locum Tenens or Reciprocal Billing
- 71.0 Modifiers SH and SJ
- 72.0 Modifiers 58, 78, 79
- 78.0 Reasonable Billing Practices
- 85.0 Therapy Services
- 86.0 Palliative Care
- 88.0 APC Payment Methodology
- 89.0 Intraoperative Monitoring
- 90.0 Chemotherapy Administration
- 92.0.PHE Telephone Services FOR COVID-19 PHE
- 95.0 Codes with TC and PC for Services Performed in Facilities
- 98.0 Advance Care Planning
- 99.0 Radiology Multiple Procedure Reduction
-
Medical, Reimbursement, and Pharmacy Policy Alerts
Medical, Reimbursement, and Pharmacy Policy Alerts
- Special Alert December 2024 - Changes Coming to Optum CES
- Special Alert December 2024 - Psychedelic Medication Therapy
- December 2024
- Special Alert - Outpatient Site of Service
- November 2024
- OHA October Proposed Changes: Value-based Benefits Subcommittee & Health Evidence Review Commission
- Special Alert October 2024 - Changes Coming to Optum CES
- October 2024
- September 2024
- Special Alert August 2024 - Carelon Multi-Factor Authentication (MFA) Migration FAQs
- August 2024
- Special Alert July 2024 - Medicaid Benefit for Access to Doula Services
- July 2024
- Special Alert June 2024 - Carelon to Introduce Multi-Factor Authentication
- June 2024
- May 2024
- Special Alert April 2024 - Alternative Care
- Special Alert April 2024 - Surgical Site of Service Policy Updates
- April 2024
- Special Alert March 2024 - PHP EM Policy
- March 2024
- February 2024
- January 2024
- Special Alert January 2024 - Yamhill Community Care Organization (YCCO)
- Special Alert December 2023 - PHP Seeks Feedback on Medicare Medical Policies
- December 2023
- November 2023
- October 2023
- Special Alert September 2023 - Inpatient Readmissions
- September 2023
- August 2023
- July 2023
- Special Alert June 2023 - Medicare Echo Scans and Nuclear Medicine
- June 2023
- May 2023
- COVID-19 Public Health Emergency Ending: Medical & Coding Policy Updates
- April 2023
- March 2023
- Special Alert February 2023 - Medicaid Review Guidelines for Early Periodic Screening Diagnostic and Treatment
- February 2023
- Special Alert January 2023 - Provider Satisfaction Survey
- January 2023
- Special Alert December 2022 - eviCore Medical Necessity Review Training
- Special Alert December 2022 (Update From October 2022 Call Out) - eviCore ASO Expansion
- Special Alert December 2022 - Covid 19 testing
- December 2022
- Special Alert December 2022 - Updates to AIM Clinical Appropriateness Guidelines
- November 2022
- Special Alert October 2022 - Covid 19 Testing
- October 2022
- September 2022
- August 2022
- July 2022
- eviCore Physical Therapy (PT) & Occupation Therapy (OT) Guidelines
- June 2022
- May 2022
- Special Alert April 2022 - InterQual 2022 Criteria Release
- April 2022
- Special Alert April 2022 - Inpatient Readmission Reimbursement Policy
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- Special Alert June 2021 - Gender Affirming Surgical Interventions
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
-
Company Medical Policies
**SPECIAL NOTICE**
Medical Policy Committee: External Provider Review
PHP/PHA Medical Policy Committee is looking to expand our group of external providers who serve as clinical subject matter experts (SMEs) through the policy development and annual review processes. We are seeking provider participation across various clinical specialties who will review and provide feedback on our medical policies. The medical policy specialties include (but are not limited to) pain management, behavioral health, endocrinology, genetics, orthopedics, neurology, urology, cardiology, oncology and general surgery. A complete list of medical policies is below.
COMPANY MEDICAL POLICIES
Specialty/Category
Allergy/Immunology
Audiology
Bariatric
Behavioral Health/ Psychiatrics
- Applied Behavior Analysis
- Biofeedback and Neurofeedback
- Extended Outpatient Psychotherapy
- Psychological and Neuropsychological Testing
- Residential Mental Health Treatment Facilities
- Transcranial Magnetic Stimulation
- Ultra-Rapid Detoxification
- Wilderness Therapy
Cardiology
- Cardiac Disease Risk Screening
- External Ambulatory Electrocardiography
- Implantable Loop Recorder
- Implantable Pulmonary Artery Pressure Monitoring
- Left Atrial Appendage Devices
- Transcatheter Aortic Valve Replacement (TAVR)
Complementary and Alternative Medicine
Definitions and Manuals
Dental/Oral Surgery
Durable Medical Equipment
- Blood Glucose Monitors and Supplies
- Compression Bandages, Stockings, and Wraps
- Continuous Passive Motion Device in the Home Setting
- Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS)
- Home Oxygen Equipment and Supplies
- Hospital Beds, Support Surfaces, and Related Accessories
- Pneumatic Compression Devices
- Seat Lift Mechanism
- Speech Generating Devices
- Standing Systems
- Transcutaneous Electrical Nerve Stimulators (TENS) and Related Supplies
- Walkers
- Wheelchairs and Power Vehicles
Emergency Services
Endocrinology
EENT
Gastroenterology
- Colorectal Cancer Screening
- Endoscopic Treatments for Gastroesophageal Reflux Disease
- Gastric Electrical Stimulation
- Magnetic Ring for Gastroesophageal Reflux Disease (GERD)
- Peroral Endoscopic Myotomy (POEM)
- Wireless Capsule Endoscopy
- Wireless Capsule for Gastrointestinal Motility Monitoring
General Surgery
Genetics
- Gene Expression Profile Testing for Melanoma
- Genetic and Molecular Testing
- Genetic Counseling
- Genetic Testing: Gene Expression Profile Testing for Breast Cancer
- Genetic Testing: Inherited Susceptibility to Colorectal Cancer
- Genetic Testing for CADASIL Disease
- Genetic Testing for Cytochrome P450 and VKORC1 Polymorphisms
- Genetic Testing for Diagnostic Evaluation of Interstitial Lung Disease
- Genetic Testing for Hereditary Breast, Ovarian, and Pancreatic Cancer Testing
- Genetic Testing for Inherited Thrombophilias
- Genetic Testing for Maturity-Onset Diabetes of the Young
- Genetic Testing for MTHFR
- Genetic Testing for Myeloproliferative Diseases
- Genetic Testing for Reproductive Planning and Prenatal Testing
- Genetic Testing for Thyroid Nodules
- Non-Covered Genetic Panel Tests
- Whole Exome, Whole Genome, and Proteogenomic Sequencing and Genetic Testing for Mitochondrial Disorders
Infectious Disease
Investigational Technologies
Lab Tests
- Alpha-Fetoprotein
- Bacterial Urine Cultures
- Blood Counts
- Direct-to-Consumer Testing
- Drug Testing for Therapeutic or Substance Use Monitoring
- Exhaled Breath Tests
- Fecal Analysis of Gastrointestinal Microbiome
- Glycated Hemoglobin and Glycated Protein Testing
- Helicobacter Pylori Serological Testing
- Hepatitis Panel and Acute Hepatitis Panel Testing
- Human Chorionic Gonadotropin
- Measurement of Antibodies to Immunosuppressive Therapies for Inflammatory Bowel Disease (IBD)
- Organic Acid Testing
- Lipid Testing
- Partial Thromboplastin Time (PTT)
- Prothrombin Time (PT)
- Salivary Hormone Testing
- Serologic Testing and Therapeutic Monitoring for Inflammatory Bowel Disease
- Serum Iron Studies
- Thyroid Testing
- Tumor Antigen Assays
- Vectra DA Test for Rheumatoid Arthritis
- Vitamin D Assay Testing
Nephrology
Neurology/Neurosurgery
- Blood Brain Barrier Disruption and Bypass
- Cochlear Implants and Auditory Brainstem Implants
- Deep Brain and Responsive Cortical Stimulation
- Magnetic Resonance-guided Focused Ultrasound Surgery
- Myoelectric Upper Limb Prosthesis
- Nerve Conduction Studies
- Surface Electromyography (sEMG) Testing
- Vagus Nerve Stimulation
Obstetrics and Gynecology
- Hysterectomy for Benign Conditions
- Pelvic Congestion Syndrome Treatment
- Planned Out of Hospital Birth
- Premature Rupture of Membranes (PROM) Testing
Oncology/Hematology
- Chemoresistance and Chemosensitivity Assays
- Circulating Tumor Cell and DNA Assays For Cancer Management
- High Intensity Focused Ultrasound
- Irreversible Electroporation (IRE) (NanoKnife System)
- Liver Tumor Treatment
- Microwave Thermotherapy for Breast Cancer
- Multimarker Serum Testing for Ovarian Cancer
- Next Generation Sequencing for Minimal Residual Disease Detection
- Next Generation Sequencing for Cancer
- Prostate Specific Antigen
- Protein Biomarker and Genetic Testing for the Prostate
- Proton Beam Radiation Therapy
- Radiofrequency Ablation of Tumors Outside the Liver
- Stem Cell Transplantation
- Stereotactic Body Radiation Therapy and Stereotactic Radiosurgery
- Tumor Testing for Targeted Therapy for Non-Small Cell Lung Cancer
- Tumor Treatment Field Therapy for Glioblastoma
Opthalmology
Orthopedics
- Ankle-Foot and Knee-Ankle-Foot Orthotics
- Autologous Chondrocyte Implantation (ACI) for Cartilaginous Defects of the Knee
- Computer Assisted Navigation for Musculoskeletal Procedures
- Electrothermal Capsular Shrinkage
- Genicular Nerve Blocks and Nerve Ablation for Knee Pain
- Joint Resurfacing
- Knee Orthotics (Functional Knee Braces)
- Lower Limb Prosthesis
- Meniscal Allograft Transplantation and Other Meniscal Implants
- Orthotic Foot Devices and Therapeutic Shoes
- Osteochondral Allografts and Autografts for Cartilaginous Defects
- Percutaneous Ultrasonic Ablation for Tendinopathy
- Platelet-Rich Plasma (PRP) for Orthopedic Indications, Wound Care and Other Misc Conditions
- Radiofrequency Ablation or Cryoablation for Plantar Fasciitis
- Surgical Site of Service
- Stem Cell Therapy for Orthopedic Applications
- Total Hip Arthroplasty
Pain Management
- Cold Therapy and Cooling Devices in the Home Setting
- Electrical Stimulation Non-Covered Therapies
- Functional Electrical Stimulation
- Ganglion Impar Blocks
- Low-Level and High-Power Laser Therapy
- Neuromuscular Drugs Botulinum Toxin
- Prolotherapy
- Spinal Epidural Steroid Injections
Physical Medicine
Plastic Surgery
- Breast Reconstructive Surgery, Reduction Mammoplasty, and Implant Management
- Cosmetic and Reconstructive Procedures
- Eye: Blepharoplasty, Blepharoptosis Repair, and Brow Lift
- Hemangioma and Vascular Malformation Laser Treatment
- Liposuction for Lipedema
- Rhinoplasty and Other Nasal Surgeries
- Surgical Treatments for Lymphedema
- Surgical Treatment for Skin Redundancy
Podiatry
Pulmonology
Research
Sleep Physicians
- Oral and Sleep Position Appliances for Sleep Disorder Treatment
- Sleep Disorder Surgery
- Sleep Disorder Testing
- Sleep Disorder Treatment with Positive Airway Pressure
Solid Organ Transplants
Spine Surgery (Neurosurgery/Orthopedic Surgery)
- Ablative Procedures to Treat Back and Neck Pain
- Artificial Intervertebral Discs
- Bone Growth Stimulators
- Discography
- Implantable Spinal Cord and Dorsal Root Ganglion Stimulation
- Intradiscal Procedures for Low Back Pain
- Intraoperative Monitoring
- Percutaneous Vertebroplasty and Sacroplasty
- Sacroiliac Joint Fusion or Stabilization
- Spinal Fusion and Decompression Procedures
- Spinal Stabilization Devices and Interspinous Spacers
Urology
Vascular Surgery
Wound Care
Alphabetical
- Ablative Procedures to Treat Back and Neck Pain
- Administrative Guideline for Dental Services
- Advanced Diabetes Management Technology
- Allergy Testing
- Alpha-Fetoprotein
- Ambulance Transport
- Ankle-Foot and Knee-Ankle-Foot Orthotics
- Apheresis (Therapeutic Pheresis)
- Applied Behavior Analysis
- Artificial Intervertebral Discs
- Athletic Pubalgia Surgery
- Autologous Chondrocyte Implantation (ACI) for Cartilaginous Defects of the Knee
- Automated Evacuation of Meibomian Gland
- Bacterial Urine Cultures
- Balloon Dilation of the Sinuses or Eustachian Tubes
- Bariatric Surgery
- Benign Prostatic Hyperplasia Treatments
- Biofeedback and Neurofeedback
- Blood Brain Barrier Disruption and Bypass
- Blood Counts
- Bone-Anchored Hearing Aids
- Bone Growth Stimulators
- Breast Reconstructive Surgery, Reduction Mammoplasty, and Implant Management
- Bronchial Thermoplasty
- Cardiac Disease Risk Screening
- Chemoresistance and Chemosensitivity Assays
- Chiropractic Care
- Circulating Tumor Cell and DNA Assays For Cancer Management
- Clinical Trials
- Cochlear Implants and Auditory Brainstem Implants
- Cold Therapy and Cooling Devices in the Home Setting
- Colorectal Cancer Screening
- Complementary and Alternative Medicine (CAM) Treatments
- Compression Bandages, Stockings, and Wraps
- Computer Assisted Navigation for Musculoskeletal Procedures
- Continuous Passive Motion Device in the Home Setting
- Corneal Collagen Cross-Linking
- Cosmetic and Reconstructive Procedures
- Covid 19 Testing
- Deep Brain and Responsive Cortical Stimulation
- Definition of Investigational
- Definition of Medical Necessity
- Dental Anesthesia Services
- Diabetes: Blood Glucose Monitors and Supplies
- Direct-to-Consumer Testing
- Discography
- Drug Testing for Therapeutic or Substance Use Monitoring
- Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS)
- Electrical Stimulation Non-Covered Therapies
- Electrothermal Capsular Shrinkage
- Endoscopic Treatments for Gastroesophageal Reflux Disease
- Exhaled Breath Tests
- Extended Outpatient Psychotherapy
- External Ambulatory Electrocardiography
- Eye: Blepharoplasty, Blepharoptosis, and Brow Lift
- Fecal Analysis of Gastrointestinal Microbiome
- Fecal Incontinence Treatments
- Foot Care Guidelines
- Functional Electrical Stimulation
- Ganglion Impar Blocks
- Gastric Electrical Stimulation
- Gender Affirming Surgical Interventions
- Gene Expression Profile Testing for Melanoma
- Genetic and Molecular Testing
- Genetic Counseling
- Genetic Testing: Gene Expression Profile Testing for Breast Cancer
- Genetic Testing: Inherited Susceptibility to Colorectal Cancer
- Genetic Testing for CADASIL Disease
- Genetic Testing for Cytochrome P450 and VKORC1 Polymorphisms
- Genetic Testing for Diagnostic Evaluation of Interstitial Lung Disease
- Genetic Testing for Hereditary Breast, Ovarian, and Pancreatic Cancer Testing
- Genetic Testing for Inherited Thrombophilias
- Genetic Testing for Maturity-Onset Diabetes of the Young
- Genetic Testing for MTHFR
- Genetic Testing for Myeloproliferative Diseases
- Genetic Testing for Reproductive Planning and Prenatal Testing
- Genetic Testing for Thyroid Nodules
- Genicular Nerve Blocks and Nerve Ablation for Knee Pain
- Glycated Hemoglobin and Glycated Protein Testing
- Hearing Aids
- Helicobacter Pylori Serological Testing
- Hemangioma and Vascular Malformation Laser Treatment
- Hepatitis Panel and Acute Hepatitis Panel Testing
- High Intensity Focused Ultrasound
- Home Oxygen Equipment and Supplies
- Hospital Beds, Support Surfaces, and Related Accessories
- Human Chorionic Gonadotropin
- Hyperbaric Oxygen Therapy
- Hysterectomy for Benign Conditions
- Implantable Loop Recorder
- Implantable Pulmonary Artery Pressure Monitoring
- Implantable Spinal Cord and Dorsal Root Ganglion Stimulation
- Intradiscal Procedures for Low Back Pain
- Intraoperative Monitoring
- Irreversible Electroporation (IRE) (NanoKnife System)
- Joint Resurfacing
- Knee Orthotics (Functional Knee Braces)
- Left Atrial Appendage Devices
- Lipid Testing
- Liposuction for Lipedema
- Liver Tumor Treatment
- Low-Level and High-Power Laser Therapy
- Lower Limb Prosthesis
- Magnetic Resonance -guided Focused Ultrasound Surgery
- Magnetic Ring for Gastroesophageal Reflux Disease (GERD)
- Measurement of Antibodies to Immunosuppressive Therapies for Inflammatory Bowel Disease (IBD)
- Meniscal Allograft Transplantation and Other Meniscal Implants
- Microwave Thermotherapy for Breast Cancer
- Multimarker Serum Testing for Ovarian Cancer
- Myoelectric Upper Limb Prosthesis
- Negative Pressure Wound Therapy
- Nerve Conduction Studies
- Neuromuscular Drugs Botulinum Toxin
- New and Emerging Technologies and Other Non-Covered Services
- Next Generation Sequencing for Minimal Residual Disease Detection
- Next Generation Sequencing for Cancer
- Non-Covered Genetic Panel Tests
- Oral and Sleep Position Appliances for Sleep Disorder Treatment
- Organ Transplantation
- Organic Acid Testing
- Orthognathic Surgery
- Orthotic Foot Devices and Therapeutic Shoes
- Osteochondral Allografts and Autografts for Cartilaginous Defects
- Partial Thromboplastin Time (PTT)
- Pelvic Congestion Syndrome Treatment
- Percutaneous Ultrasonic Ablation for Tendinopathy
- Percutaneous Vertebroplasty and Sacroplasty
- Peroral Endoscopic Myotomy (POEM)
- Planned Out of Hospital Birth
- Platelet-Rich Plasma (PRP) for Orthopedic Indications, Wound Care and Other Misc Conditions
- Pneumatic Compression Devices
- Premature Rupture of Membranes (PROM) Testing
- Prolotherapy
- Prostate Specific Antigen
- Protein Biomarker and Genetic Testing for the Prostate
- Prothrombin Time (PT)
- Proton Beam Radiation Therapy
- Psychological and Neuropsychological Testing
- Radiofrequency Ablation or Cryoablation for Plantar Fasciitis
- Radiofrequency Ablation of Tumors Outside the Liver
- Residential Mental Health Treatment Facilities
- Respiratory Viral Panels
- Rhinoplasty and Other Nasal Surgeries
- Sacroiliac Joint Fusion or Stabilization
- Salivary Hormone Testing
- Seat Lift Mechanism
- Serologic Testing and Therapeutic Monitoring for Inflammatory Bowel Disease
- Serum Iron Studies
- Skin and Tissue Substitutes
- Sleep Disorder Surgery
- Sleep Disorder Testing
- Sleep Disorder Treatment with Positive Airway Pressure
- Speech Generating Devices
- Spinal Epidural Steroid Injections
- Spinal Fusion and Decompression Procedures
- Spinal Stabilization Devices and Interspinous Spacers
- Standing Systems
- Stem Cell Therapy for Orthopedic Applications
- Stem Cell Transplantation
- Stereotactic Body Radiation Therapy and Stereotactic Radiosurgery
- Surface Electromyography (sEMG) Testing
- Surgical Site of Service
- Surgical Treatment for Skin Redundancy
- Surgical Treatments for Lymphedema
- Thyroid Testing
- Total Hip Arthroplasty
- Transcatheter Aortic Valve Replacement (TAVR)
- Transcranial Magnetic Stimulation
- Transcutaneous Electrical Nerve Stimulators (TENS) and Related Supplies
- Tumor Antigen Assays
- Tumor Testing for Targeted Therapy for Non-Small Cell Lung Cancer
- Tumor Treatment Field Therapy for Glioblastoma
- Ultra-Rapid Detoxification
- Urinary Dysfunction Treatments
- Vagus Nerve Stimulation
- Varicose Veins
- Vectra DA Test for Rheumatoid Arthritis
- Vestibular Function Testing
- Vitamin D Assay Testing
- Walkers
- Wheelchairs and Power Vehicles
- Whole Exome, Whole Genome, and Proteogenomic Sequencing and Genetic Testing for Mitochondrial Disorders
- Wilderness Therapy
- Wireless Capsule Endoscopy
- Wireless Capsule for Gastrointestinal Motility Monitoring
-
Medicare Medical Policies
**SPECIAL NOTICE**
Medical Policy Committee: External Provider Review - Medicare Medical Policies
PHP/PHA Medical Policy Committee is looking to expand our group of external providers, in particular those with expertise in the clinical care of elderly or disabled patients, to serve as clinical subject matter experts (SMEs) through the policy development and annual review processes. We encourage provider participation across various clinical specialties who will review and provide feedback on our Medicare Advantage medical policies. Specialties include (but are not limited to) pain management, behavioral health, endocrinology, genetics, orthopedics, neurology, urology, cardiology, oncology and general surgery. A complete list of Medicare Advantage medical policies is below.
MEDICARE MEDICAL POLICIES
Specialty/Category
Allergy/Immunology
Audiology
Bariatric
Behavioral Health/ Psychiatrics
Cardiology
- Cardiac Disease Risk Screening
- External Ambulatory Electrocardiography
- Implantable Loop Recorders
- Implantable Pulmonary Artery Pressure Monitoring
- Left Atrial Appendage Devices
- Transcatheter Aortic Valve Replacement (TAVR)
Complementary and Alternative Medicine
Definitions and Manuals
- Definition of Medically Reasonable and Necessary (Medical Necessity)
- PHA Medicare Medical Policy Development and Application
Dental/Oral Surgery
Durable Medical Equipment
- Blood Glucose Monitors and Supplies
- Compression Bandages, Stockings, and Wraps
- Continuous Passive Motion Devices in the Home Setting
- Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS)
- Home Oxygen Equipment and Supplies
- Hospital Beds, Support Surfaces, and Related Accessories
- Pneumatic Compression Devices
- Seat Lift Mechanism
- Speech Generating Devices
- Standing Systems
- Walkers
- Wheelchairs and Power Vehicles
Emergency Services
Endocrinology
EENT
Gastroenterology
- Endoscopic Treatments for Gastroesophageal Reflux Disease (GERD)
- Magnetic Esophageal Ring for Gastroesophageal Reflux Disease (GERD)
- Peroral Endoscopic Myotomy (POEM)
- Wireless Capsule Endoscopy
- Wireless Capsule for Gastrointestinal Motility Monitoring
General Surgery
Genetics
- Gene Expression Profile Testing for Melanoma
- Gene Expression Profile Testing for Breast Cancer
- Genetic and Molecular Testing
- Genetic Testing for Myeloproliferative Diseases
- Genetic Testing for Thyroid Nodules
Infectious Disease
New and Emerging Technologies
Lab Tests
- Alpha-Fetoprotein
- Bacterial Urine Cultures
- Blood Counts
- Drug Testing for Therapeutic or Substance Use Monitoring
- Exhaled Breath Tests
- Fecal Analysis of Gastrointestinal Microbiome
- Glycated Hemoglobin and Glycated Protein Testing
- Helicobacter Pylori Serological Testing
- Hepatitis Panel and Acute Hepatitis Panel Testing
- Human Chorionic Gonadotropin
- Measurement of Antibodies to Immunosuppressive Therapies for Inflammatory Bowel Disease (IBD)
- Organic Acid Testing
- Lipid Testing
- Partial Thromboplastin Time (PTT)
- Prothrombin Time (PT)
- Salivary Hormone Testing
- Serologic Testing and Therapeutic Monitoring for Inflammatory Bowel Disease
- Serum Iron Studies
- Thyroid Testing
- Tumor Antigen Assays
- Vitamin D Assay Testing
Nephrology
Neurology/Neurosurgery
- Blood Brain Barrier Disruption and Bypass
- Cochlear Implants and Auditory Brainstem Implants
- Magnetic Resonance-Guided Focused Ultrasound Surgery
- Myoelectric Upper Limb Prosthesis
- Nerve Conduction Studies
- Surface Electromyography (sEMG) Testing
Obstetrics and Gynecology
Oncology/Hematology
- Chemosensitivity and Chemoresistance Assays (CSRAs)
- Circulating Tumor Cell and DNA Assays For Cancer Management
- Irreversible Electroporation (IRE) (NanoKnife System)
- Liver Tumor Treatment
- Microwave Thermotherapy for Breast Cancer
- Next Generation Sequencing for Minimal Residual Disease Detection
- Protein Biomarker and Genetic Testing for the Prostate
- Prostate Specific Antigen
- Proton Beam Radiation Therapy
- Radiofrequency Ablation for Tumors Outside the Liver
- Stem Cell Transplantation
Orthopedics
- Ankle-Foot and Knee-Ankle-Foot Orthotics
- Autologous Chondrocyte Implantation (ACI) for Cartilaginous Defects of the Knee
- Computer Assisted Navigation for Musculoskeletal Procedures
- Electrothermal Capsular Shrinkage
- Genicular Nerve Blocks and Nerve Ablation for Knee Pain
- Joint Resurfacing
- Knee Orthotics (Functional Knee Braces)
- Lower Limb Prosthesis
- Meniscal Allograft Transplant and Other Meniscal Implants
- Orthotic Foot Devices and Therapeutic Shoes
- Osteochondral Allografts and Autografts for Cartilaginous Defects
- Percutaneous Ultrasonic Ablation for Tendinopathy
- Platelet-Rich Plasma (PRP) for Orthopedic Indications, Wound Care and Other Misc Conditions
- Radiofrequency Ablation and Cryoablation for Plantar Fasciitis
- Surgical Site of Service
- Stem Cell Therapy for Orthopedic Applications
- Total Hip Arthroplasty
- Viscosupplementation
- Cold Therapy and Cooling Devices in the Home Setting
- Electrical Stimulation and Electromagnetic Therapies
- Ganglion Impar Blocks
- Low-Level and High-Power Laser Therapy
- Neuromuscular Drugs Botulinum Toxin
- Prolotherapy
- Spinal Epidural Steroid Injections
Plastic Surgery
- Blepharoplasty, Blepharoptosis Repair, and Brow Lift
- Breast Reconstructive Surgery, Implant Management, and Reduction Mammoplasty
- Cosmetic and Reconstructive Procedures
- Hemangioma and Vascular Malformation Laser Treatment
- Liposuction for Lipedema
- Rhinoplasty and Other Nasal Surgeries
- Surgical Treatments for Lymphedema
- Surgical Treatment for Skin Redundancy
Podiatry
Pulmonology
Research
Sleep Physicians
- Oral and Sleep Position Appliances for Sleep Disorder Treatment
- Sleep Disorder Surgery
- Sleep Disorder Testing
- Sleep Disorder Treatment with Positive Airway Pressure
Solid Organ Transplants
Spine Surgery (Neurosurgery/Orthopedic Surgery)
- Ablative Procedures to Treat Back and Neck Pain
- Administrative Guideline for Dental Services
- Artificial Intervertebral Discs
- Bone Growth Stimulators
- Discography
- Intradiscal Procedures for Low Back Pain
- Intraoperative Monitoring
- Percutaneous Vertebroplasty and Sacroplasty
- Sacroiliac Joint Fusion or Stabilization
- Spinal Fusion and Decompression Procedures
- Spinal Stabilization Devices and Interspinous Spacers
Urology
Vascular Surgery
Wound Care
Alphabetical
- Ablative Procedures to Treat Back and Neck Pain
- Advanced Diabetes Management Technology
- Allergy Testing
- Alpha-Fetoprotein
- Ambulance Transport
- Ankle-Foot and Knee-Ankle-Foot Orthotics
- Apheresis (Therapeutic Pheresis)
- Artificial Intervertebral Discs
- Athletic Pubalgia Surgery
- Autologous Chondrocyte Implantation (ACI) for Cartilaginous Defects of the Knee
- Automated Evacuation of the Meibomian Gland
- Bacterial Urine Cultures
- Balloon Dilation of the Sinuses or Eustachian Tubes
- Bariatric Surgery
- Blepharoplasty, Blepharoptosis Repair, and Brow Lift
- Blood Brain Barrier Disruption and Bypass
- Blood Counts
- Blood Glucose Monitors and Supplies
- Bone-Anchored Hearing Aids
- Bone Growth Stimulators
- Breast Reconstructive Surgery, Implant Management, and Reduction Mammoplasty
- Bronchial Thermoplasty
- Cardiac Disease Risk Screening
- Chemosensitivity and Chemoresistance Assays (CSRAs)
- Chiropractic Care
- Circulating Tumor Cell and DNA Assays For Cancer Management
- Clinical Trials, Studies and Registries
- Cochlear Implants and Auditory Brainstem Implants
- Cold Therapy and Cooling Devices in the Home Setting
- Complementary and Alternative Medicine (CAM) Treatments
- Compression Bandages, Stockings, and Wraps
- Computer Assisted Navigation for Musculoskeletal Procedures
- Continuous Passive Motion Devices in the Home Setting
- Cosmetic and Reconstructive Procedures
- Covid 19 Testing
- Definition of Medically Reasonable and Necessary (Medical Necessity)
- Dental Anesthesia Services
- Discography
- Drug Testing for Therapeutic or Substance Use Monitoring
- Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS)
- Electrical Stimulation and Electromagnetic Therapies
- Electrothermal Capsular Shrinkage
- Endoscopic Treatments for Gastroesophageal Reflux Disease (GERD)
- Exhaled Breath Tests
- Extended Outpatient Psychotherapy
- External Ambulatory Electrocardiography
- Fecal Analysis of Gastrointestinal Microbiome
- Fecal Incontinence Treatments
- Foot Care Guidelines
- Ganglion Impar Blocks
- Gender Affirming Surgical Interventions
- Gene Expression Profile Testing for Melanoma
- Gene Expression Profile Testing for Breast Cancer
- Genetic and Molecular Testing
- Genetic Testing for Myeloproliferative Diseases
- Genetic Testing for Thyroid Nodules
- Genicular Nerve Blocks and Nerve Ablation for Knee Pain
- Glycated Hemoglobin and Glycated Protein Testing
- Helicobacter Pylori Serological Testing
- Hemangioma and Vascular Malformation Laser Treatment
- Hepatitis Panel and Acute Hepatitis Panel Testing
- Home Oxygen Equipment and Supplies
- Hospital Beds, Support Surfaces, and Related Accessories
- Human Chorionic Gonadotropin
- Hyperbaric Oxygen Therapy
- Implantable Loop Recorders
- Implantable Pulmonary Artery Pressure Monitoring
- Intradiscal Procedures for Low Back Pain
- Intraoperative Monitoring
- Irreversible Electroporation (IRE) (NanoKnife System)
- Joint Resurfacing
- Knee Orthotics (Functional Knee Braces)
- Lipid Testing
- Liposuction for Lipedema
- Liver Tumor Treatment
- Left Atrial Appendage Devices
- Low-Level and High-Power Laser Therapy
- Lower Limb Prosthesis
- Magnetic Esophageal Ring for Gastroesophageal Reflux Disease (GERD)
- Magnetic Resonance-Guided Focused Ultrasound Surgery
- Measurement of Antibodies to Immunosuppressive Therapies for Inflammatory Bowel Disease (IBD)
- Meniscal Allograft Transplant and Other Meniscal Implants
- Microwave Thermotherapy for Breast Cancer
- Myoelectric Upper Limb Prosthesis
- Negative Pressure Wound Therapy (NPWT)
- Nerve Conduction Studies
- Neuromuscular Drugs Botulinum Toxin
- New and Emerging Technologies and Other Non-Covered Services
- Next Generation Sequencing for Minimal Residual Disease Detection
- Oral and Sleep Position Appliances for Sleep Disorder Treatment
- Organ Transplantation
- Organic Acid Testing
- Orthognathic Surgery
- Orthotic Foot Devices and Therapeutic Shoes
- Osteochondral Allografts and Autografts for Cartilaginous Defects
- Partial Thromboplastin Time (PTT)
- Pelvic Congestion Syndrome Treatment
- Percutaneous Ultrasonic Ablation for Tendinopathy
- Percutaneous Vertebroplasty and Sacroplasty
- Peroral Endoscopic Myotomy (POEM)
- PHA Medicare Medical Policy Development and Application
- Platelet-Rich Plasma (PRP) for Orthopedic Indications, Wound Care and Other Misc Conditions
- Pneumatic Compression Devices
- Premature Rupture of Membranes (PROM) Testing
- Prolotherapy
- Protein Biomarker and Genetic Testing for the Prostate
- Prostate Specific Antigen
- Prothrombin Time (PT)
- Proton Beam Radiation Therapy
- Radiofrequency Ablation and Cryoablation for Plantar Fasciitis
- Radiofrequency Ablation for Tumors Outside the Liver
- Respiratory Viral Panels
- Rhinoplasty and Other Nasal Surgeries
- Sacroiliac Joint Fusion or Stabilization
- Salivary Hormone Testing
- Seat Lift Mechanism
- Serologic Testing and Therapeutic Monitoring for Inflammatory Bowel Disease
- Serum Iron Studies
- Skin and Tissue Substitutes
- Sleep Disorder Surgery
- Sleep Disorder Testing
- Sleep Disorder Treatment with Positive Airway Pressure
- Speech Generating Devices
- Spinal Epidural Steroid Injections
- Spinal Fusion and Decompression Procedures
- Spinal Stabilization Devices and Interspinous Spacers
- Standing Systems
- Stem Cell Therapy for Orthopedic Applications
- Stem Cell Transplantation
- Surface Electromyography (sEMG) Testing
- Surgical Site of Service
- Surgical Treatment for Skin Redundancy
- Surgical Treatments for Lymphedema
- Thyroid Testing
- Total Hip Arthroplasty
- Transcatheter Aortic Valve Replacement (TAVR)
- Transcranial Magnetic Stimulation
- Tumor Antigen Assays
- Ultra-rapid Detoxification
- Urinary Dysfunction Treatments
- Varicose Veins
- Vestibular Function Testing
- Viscosupplementation
- Vitamin D Assay Testing
- Walkers
- Wheelchairs and Power Vehicles
- Wireless Capsule Endoscopy
- Wireless Capsule for Gastrointestinal Motility Monitoring
-
Provider Satisfaction Survey
Provider Satisfaction Survey
Providence cares about the experience of our providers. Please click the link below to provide feedback on your experience as a provider working with Providence Health Plan. We look forward to hearing from you.
Thank you!
-
Credentialing Services
-
Reimbursement Policies
REIMBURSEMENT POLICIES
Medical Services
+ Ambulatory Surgery Center (ASC) Payment Structure
+ Associated Services and Related Claims
+ Emergency Department Evaluation & Management Services
+ Facility Routine Supplies and Services
+ Inpatient Hospital Admission and Length of Stay Reviews
+ Outpatient Hospital Services Rendered Prior to an Inpatient Admission
+ Scope of License, Scope of Practice, and Provider Qualification
For questions related to medical reimbursement policies please contact our PHP Reimbursement Policy Team at PHPReimbursementPolicy@providence.org
Pharmacy Reimbursement Policies
+ Medical Drug Reimbursement: Outpatient and Inpatient
For questions related to pharmacy reimbursement policies please contact our PHP Pharmacy Policy Team at PHPPharmacySpecialtyTeam@providence.org
-
Pharmacy Policies
Medical Benefit Drug Search Tool - Click[HERE] -for all lines of business
NDC Required for Medical Claims Reimbursement effective 11/1/2023
Providence Health Plan (PHP) requires providers to submit National Drug Codes (NDCs) on provider drug claims and hospital outpatient facility claims that are reported for reimbursement.
-
Pharmacy Reimbursement Policy Medical Drug Reimbursement: Outpatient and Inpatient revised and approved by ORPTC in June 2024.
National Drug Code (NDC) numbers are the industry standard identifier for drugs and provide full transparency to the medication administered. The NDC number identifies the manufacturer, drug name, dosage, strength, package size and quantity.
For purposes of this policy, a valid NDC number, NDC unit of measure and NDC units dispensed for the drug administered will be required for reimbursement of professional drug claims on a1500 Health Insurance Claim Form (a/k/a CMS-1500), the 837-professional transaction, a UB-04 Claim Form or the 837i facility transaction.
More Members Eligible for Copay Maximizer Program
On January 1st, 2024, Providence Health Plan is expanding the opportunity of the Smart RxAssist Copay Maximizer program to all fully insured Oregon non-HSA members. This program optimizes the use of manufacturer copay assistance on specialty medications.
- Captures the maximum benefit of manufacturer copay cards
- Reduces member copay responsibility to $0
- Up to 10-15% reduction in plan sponsor’s specialty drug cost
As fully insured groups renew their PHP plans, the group will become eligible for the Smart Rx Assist program. For groups renewing 1/1/24, members who are on specialty medications that quality for manufacturer copay coupons will be mailed out letters on December 10th, 2024.
Medical Benefit Drug Prior Authorization
Below you will find lists of drugs with their associated medical necessity criteria for coverage. Please select the list of drugs based on the medical plan of your patient (e.g., Commercial, Medicaid, Medicare). You may use the drug prior authorization request form below to request authorization for a drug.
Please note that the presence of drugs on these lists does not indicate that the particular drug will be covered under your patient’s medical or prescription drug benefit. You can verify drug coverage by accessing your patient’s formulary on the Providence Health Plan pharmacy resources page.
Formulary exceptions: There may be times that you prescribe a drug that is not on your patient’s formulary. You may want to consider prescribing a formulary alternative for your patient; however, you may also request a formulary exception for the drug you wish to prescribe by using the drug prior authorization form below.
Drug Prior Authorization Request Form
Medical Benefit Drug Search Tool - Click[HERE] -for all lines of business
Medicare Part B
- 2024 Step Therapy Drug List for Medicare Part B
- 2024 Prior Authorization Criteria for Medicare Part B Drugs
- 2025 Step Therapy Drug List for Medicare Part B
- 2025 Prior Authorization Criteria for Medicare Part B Drugs
Biosimilar Preferred Product Program
Providence Health Plan (PHP) implemented a biosimilar preferred product formulary strategy for medical benefit drugs effective July 1, 2021. Use the above Medical Benefit Drug Search Tool to easily find preferred Biosimilars.
Infusion Therapy Site of Care (SOC)
Providence Health Plan (PHP) requires site of care prior authorization for the medications listed below when given in an unapproved hospital setting. A separate prior authorization may be required for the drug. Refer to the Commercial Infusion Therapy SOC Policy link below.
- Infusion Therapy SOC Policy - Effective 1/1/2024
- Infusion Therapy SOC Policy - Effective 10/1/2024
- Site of Care Prior Authorization Request Form
Infusion Therapy Site of Care Facility Contracting:
- Approved Site of Care Facility List
- 2024 Outpatient Infusion Services SOC Contract list of Drug Codes - Effective 2/1/2024
- 2025 Outpatient Infusion Services SOC Contract list of Drug Codes - Effective 1/1/2025
Specialty Drugs Shipped from Pharmacies to Providers and Facilities ("White Bagging")
- Specialty Drugs Shipped from Pharmacies to Providers and Facilities - Operational Policy
Self-Administered Drug Exclusion Policy
Self-Administered Drugs definition - Medications which have been identified as being medically appropriate for administration by a patient or caregiver, safely and effectively, without medical supervision.
Certain medications considered to be usually self-administered by the patient or their caregiver are excluded from coverage under the medical benefit without prior-authorization.
- Self-Administered Drug Exclusion Policy - Commercial and Medicaid
- Medicare Part B – Refer to Noridian Healthcare Solutions’ Self-Administered Drugs (SADs) Policy: https://med.noridianmedicare.com/web/jfb/policies/sads
- Self-Administered Drug Exclusion Drug List - Applies to All Lines of Business
Opioid Resources and Guidelines
- PHP has created a list of links designed to empower providers to make evidence based decisions when starting opioid therapy as well provide support when taper is indicated.
-
-
Outpatient Rehabilitation
NEW 6.1.2024
Special Announcement: We are pleased to announce that Providence Health Plan, being true to ourselves of “Know me, Care for me, Ease my way”, has made the decision to ease the way for our members aged 18 and younger, by removing select pediatric diagnosis codes from requiring prior authorization review through eviCore for outpatient rehabilitation.
Please see Excluded Pediatric Diagnosis Codes for a complete list
eviCore ASO Expansion
Please be aware that Self-Funded Administrative Only (ASO) group plans require eviCore medical necessity reviews for outpatient rehabilitation. Providers will need to request medical necessity review through eviCore healthcare. Please see below for additional details
Please note that Providence will continue to require a request to eviCore on all Commercial, Fully Insured, and Individual members.
For additional information, including eviCore’s clinical guidelines and a complete list of services requiring medical necessity review, please visit: https://www.evicore.com/resources/healthplan/providence-health-plan or call the eviCore Client Provider Operations department at (800) 646-0418 (Option #4).
Effective 1/1/2025:
- Marathon Coach
The following ASO plans do not require eviCore:
- Intel
eviCore Web Portal Training Sessions
Outpatient Rehabilitation Resources
-
Health Related Social Needs (HRSN)
Health Related Social Needs (HRSN)
3/1/2024 Oregon Health Authority (OHA) implemented a new benefit, Health Related Social Needs (HRSN). This benefit allows certain eligible members that meet certain criteria to receive Climate-Related Supports. PHA’s process requires a member, member representative, provider, or Community Based Organization, to request this support utilizing the HRSN Benefit Request form below.
-
Climate-Related Supports are climate-related devices and services provided to an eligible member with an HRSN authorization to utilize in their own home or non-institutional, non-congregate primary residence, and for whom which equipment and support are Clinically Appropriate as a component of health services treatment or prevention.
-
Clinically Appropriate Climate-Related Devices:
-
Air Conditioners for individuals at health risk due to significant heat,
-
Heaters for individuals at increased health risk due to significant cold,
-
Air filtration devices and, as needed, replacement air filters for individuals at health risk due to compromised air quality,
-
Mini refrigeration units as needed for individuals for medication storage, and
-
Portable power supplies (PPSs) for individuals who need access to electricity-dependent equipment (e.g., ventilators, dialysis machines, intravenous equipment, chair lifts, mobility devices, communication devices, etc.) or are at risk of public safety power shutoffs (PSPS) that may compromise their ability to use medically necessary devices.
-
To receive a Climate-Related Device, members must attest to their ability to safely use the devices to reduce the risk of injury or harm. The safe use of devices requires that a member reside in a non-institutional, non-congregate housing or “recreational vehicle”, that has a reliable source of electricity for operating a device, and that the member or their representative can safely and legally install the device in their place of residence.
-
In the event the above conditions cannot be met, the HRSN Eligible Member may not be authorized for receipt of the Climate-Related device.
-
Eligibility for Climate-Related Supports for a PHA HSO Member:
-
To be eligible for Climate-Related Supports an individual must meet all of the following requirements:
-
Be enrolled in OHP through Health Share of Oregon-Providence
-
Be in at least one HRSN Covered Population
-
Meet at least one of the HRSN Climate Device Clinical Risk Factors
-
Meet criteria for HRSN Climate Device Social Risk Factor, which includes meeting safe use requirements for the device(s) and not already receiving the same or substantially similar services from a local, state, or federally funded program.
-
HRSN Covered Populations:
-
Member must be in one of the following HRSN Covered Populations to be eligible:
-
Adults and Youth Discharged from an IMD
-
Adults and Youths Released from Incarceration
-
Individuals Involved with Child Welfare
-
Individuals Transitioning to Dual Status
-
Individuals who are Homeless or At Risk of Homelessness
-
If you are a member, member representative, provider of a member, or Community Based Organization and would like to submit a request for the HRSN benefit, please use the form provided below and submit the form to Providence via email at: HRSNBenefit@providence.org
-
For questions, please email us at: HRSNBenefit@Providence.org
-
-
No Surprises Act
Reimbursement to providers and facilities for services subject to the No Surprises Act are paid according to the qualifying payment amount (QPA) as defined by the No Surprises Act. The methodology for calculating the QPA was determined by the Plan to be consistent with the requirements of the No Surprises Act. If the out-of-network provider or facility wishes to initiate a 30 business day negotiation period, they may contact ClearHealth via https://clearhs.com, claimsinquiry@clearhs.com, or by calling (866) 722-3773. Independent Dispute Resolution may be initiated within 4 days after the end of the 30 day negotiation period.
-
Contact Us
The PHP Medical Policy Team only deals with evidence-based reviews around published medical policies. All inquiries concerning PHP medical policies or new medical devices and technologies may be sent by filling out our online form
Do not submit the Medical Policy Inquiry Feedback form for questions regarding pricing, benefits, claims, EOB statements, or contract issues. Medical policy staff cannot answer or forward these issues. Please contact Customer Service or Provider Relations for assistance with the above.
If you are a member please do not use this form. Please call customer service.
Medical Policy Inquiry FormProvider Relations can be contacted here: https://healthplans.providence.org/providers/provider-support/provider-relations-representatives/
Customer Service can be reached at: 503-574-7500 or 800-878-4445 (TTY: 711); or at https://healthplans.providence.org/about-us/contact-us/
For questions related to pharmaceuticals please contact our PHP Pharmacy Policy Team at PHPRX@providence.org
For questions related to reimbursement policies please contact our PHP Reimbursement Policy Team at PHPReimbursementPolicy@providence.org